Yu, Z., Cai, X., Xu, Z., He, Z., Lai, J., Wang, W., . . . Huang, C. (2020). Apatinib plus Chemotherapy as a Second‐Line Treatment in Unresectable Non‐Small Cell Lung Carcinoma: A Randomized, Controlled, Multicenter Clinical Trial. Oncologist.
Chicago Style citaatYu, Zongyang, et al. "Apatinib Plus Chemotherapy As a Second‐Line Treatment in Unresectable Non‐Small Cell Lung Carcinoma: A Randomized, Controlled, Multicenter Clinical Trial." Oncologist 2020.
MLA citatieYu, Zongyang, et al. "Apatinib Plus Chemotherapy As a Second‐Line Treatment in Unresectable Non‐Small Cell Lung Carcinoma: A Randomized, Controlled, Multicenter Clinical Trial." Oncologist 2020.
Let op: Deze citaties zijn niet altijd 100% accuraat.